Publications by authors named "A Obr"

Claim this Profile
E
Enhancing prognostic accuracy in PMBCL: semiquantitative analysis of interim PET/CT scans.
V Hanáčková, K Polgárová, L Henzlová, D Zogala, A Obr

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fundamental prognostic difference of ATM gene mutation and deletion in newly diagnosed mantle cell lymphoma.
Ales Obr, Diana Malarikova, Eva Kriegova, Helena Urbankova, Zuzana Zemanova

Mol Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration.
Alice Sýkorová, František Folber, Kamila Polgárová, Heidi Móciková, Juraj Ďuraš, Aleš Obr

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, Rui Bergantim, Francesca Farina, Aleš Obr

Hematol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells.
Ondřej Mitrovský, Denisa Myslivcová, Tereza Macháčková-Lopotová, Adam Obr, Kamila Čermáková

PLoS One· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis